Laboratorios Farmaceuticos Rovi SA

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

8.72%

Market Cap

3.00 Bil.

P/E Ratio

23.13

Dividend Yield

1.22 %

Earnings per Share

2.75 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE58.6 G0 Units
PRICE DETERMINATION TIME07/24/2026 / 09:57:09 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW5957.7
PREV. DAY'S PRICE58.45 (07/23)
CHANGE DAY BEFORE
+0.15
0.26 %
52 WEEK HIGH / LOW86.55 (04/21)51.65 (08/06)

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
3.292.682.752.503.43
DIVIDENDS PER SHARE
0.890.760.780.961.18
DIVIDEND YIELD IN %
1.49 %1.20 %1.22 %--
DIVIDEND GROWTH IN %
-14.69 %-15.28 %2.60 %--
PRICE - EARNINGS RATIO
18.3123.5223.1323.2416.94
PRICE - BOOK RATIO
5.785.634.89--
PRICE - SALES RATIO
3.764.224.37--
PRICE - CASH FLOW RATIO
27.2823.5617.52--
Further Key Figures

Master Data

WKN
A0M0GQ
ISIN
ES0157261019
SYMBOL
41L
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
LABORATORIOS FARMACEUT.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
51.15 Mil.
MARKET CAPITALISATION
3.00 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
8.82 %
-1.10 %
-27.92 %
-19.95 %
8.72 %
40.39 %
-0.34 %
-6.91 %
HIGH59.0059.6081.9586.5586.5591.4091.4086.55
LOW53.6052.8552.8552.8551.6541.0635.4452.85

Dividende

pro Aktie

Company profile

Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.